These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity. Lima WF; Brown-Driver V; Fox M; Hanecak R; Bruice TW J Biol Chem; 1997 Jan; 272(1):626-38. PubMed ID: 8995306 [TBL] [Abstract][Full Text] [Related]
25. Synthesis of chimeric oligonucleotides containing phosphodiester, phosphorothioate, and phosphoramidate linkages. Maier MA; Guzaev AP; Manoharan M Org Lett; 2000 Jun; 2(13):1819-22. PubMed ID: 10891166 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Watson PH; Pon RT; Shiu RP Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215 [TBL] [Abstract][Full Text] [Related]
27. Antisense phosphorothioate oligodeoxyribonucleotide targeted against ICAM-1: synthetic and biological characterization of a process-related impurity formed during oligonucleotide synthesis. Ravikumar VT; Capaldi DC; Lima WF; Lesnik E; Turney B; Cole DL Bioorg Med Chem; 2003 Oct; 11(21):4673-9. PubMed ID: 14527564 [TBL] [Abstract][Full Text] [Related]
28. A naked antisense oligonucleotide with phosphorothioate linkages is taken up intracellularly more efficiently but functions less effectively. Takahashi M; Seki M; Nashimoto M Biochem Biophys Res Commun; 2021 Oct; 573():140-144. PubMed ID: 34411896 [TBL] [Abstract][Full Text] [Related]
29. Phosphorothioate oligonucleotides induction into experimental choroidal neovascularization by HVJ-liposome system. Ogata N; Otsuji T; Matsushima M; Kimoto T; Yamanaka R; Takahashi K; Wada M; Uyama M; Kaneda Y Curr Eye Res; 1999 Apr; 18(4):261-9. PubMed ID: 10372985 [TBL] [Abstract][Full Text] [Related]
30. Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis. Ramazeilles C; Mishra RK; Moreau S; Pascolo E; Toulmé JJ Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7859-63. PubMed ID: 8058724 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of collagenase type I expression by psoralen antisense oligonucleotides in dermal fibroblasts. Lin M; Hultquist KL; Oh DH; Bauer EA; Hoeffler WK FASEB J; 1995 Oct; 9(13):1371-7. PubMed ID: 7557028 [TBL] [Abstract][Full Text] [Related]
32. Antisense and/or immunostimulatory oligonucleotide therapeutics. Agrawal S; Kandimalla ER Curr Cancer Drug Targets; 2001 Nov; 1(3):197-209. PubMed ID: 12188879 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide. Watson PH; Pon RT; Shiu RP Exp Cell Res; 1992 Oct; 202(2):391-7. PubMed ID: 1397092 [TBL] [Abstract][Full Text] [Related]
34. Nucleotide pyrophosphatase/phosphodiesterase 1 is responsible for degradation of antisense phosphorothioate oligonucleotides. Wójcik M; Cieślak M; Stec WJ; Goding JW; Koziołkiewicz M Oligonucleotides; 2007; 17(1):134-45. PubMed ID: 17461770 [TBL] [Abstract][Full Text] [Related]
35. Stability of polycationic complexes of an antisense oligonucleotide in rat small intestine homogenates. González Ferreiro M; Crooke RM; Tillman L; Hardee G; Bodmeier R Eur J Pharm Biopharm; 2003 Jan; 55(1):19-26. PubMed ID: 12551700 [TBL] [Abstract][Full Text] [Related]
36. Absolute bioavailability of 2'-O-(2-methoxyethyl)-modified antisense oligonucleotides following intraduodenal instillation in rats. Geary RS; Khatsenko O; Bunker K; Crooke R; Moore M; Burckin T; Truong L; Sasmor H; Levin AA J Pharmacol Exp Ther; 2001 Mar; 296(3):898-904. PubMed ID: 11181922 [TBL] [Abstract][Full Text] [Related]
37. Analysis of antisense oligonucleotides by capillary electrophoresis, gel-slab electrophoresis, and HPLC: a comparison. Gelfi C; Perego M; Morelli S; Nicolin A; Righetti PG Antisense Nucleic Acid Drug Dev; 1996; 6(1):47-53. PubMed ID: 8783795 [TBL] [Abstract][Full Text] [Related]
38. Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-alpha by the incorporation of 2'-O-propyl modifications. McKay RA; Cummins LL; Graham MJ; Lesnik EA; Owens SR; Winniman M; Dean NM Nucleic Acids Res; 1996 Feb; 24(3):411-7. PubMed ID: 8602351 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Saijo Y; Perlaky L; Wang H; Busch H Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900 [TBL] [Abstract][Full Text] [Related]
40. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys. Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]